Status:
COMPLETED
COVID-19 SAFE Enrollment
Lead Sponsor:
University of Pennsylvania
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In order to safely and effectively reopen businesses and universities across the US, institutions will need to develop approaches to rapidly identify COVID-19 cases and manage their spread while balan...
Detailed Description
The coronavirus disease 2019 (COVID-19) pandemic has resulted in close to 10,000,000 reported cases worldwide, including more than 2,000,000 aggregated reported cases and 120,000 deaths in the United ...
Eligibility Criteria
Inclusion
- •University of Pennsylvania staff, faculty, and trainees that have returned to work on campus who have been identified by leadership at the University of Pennsylvania Perelman School of Medicine.
Exclusion
- •Participants will not be eligible for the study if they identify any reason they are unable to participate in the study.
Key Trial Info
Start Date :
September 9 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 30 2020
Estimated Enrollment :
412 Patients enrolled
Trial Details
Trial ID
NCT04506268
Start Date
September 9 2020
End Date
October 30 2020
Last Update
March 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Penn Medicine
Philadelphia, Pennsylvania, United States, 19103